Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease
NCT02233907 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 595
Last updated 2014-09-09
Summary
Study to obtain further information on the tolerability and efficacy of Ventilat® metered dose inhaler in long-term treatment of Chronic Obstructive Pulmonary Disease under conditions of daily practice
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
- DRUG
-
Ventilat® - metered dose inhaler
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-10-31
- Primary Completion
- 2001-08-31
More Related Trials
-
Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease
NCT02238197 ·Status: COMPLETED
-
Postmarketing Surveillance Study of Atrovent® in Chronic Obstructive Airways Disease
NCT02236715 ·Status: COMPLETED
-
Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease
NCT02238145 ·Status: COMPLETED
-
Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
NCT02238158 ·Status: COMPLETED
-
Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease
NCT02232594 ·Status: COMPLETED
-
Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Airways Disease
NCT02231424 ·Status: COMPLETED
-
Postmarketing Surveillance Study of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease
NCT02244216 ·Status: COMPLETED
-
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
NCT02552160 ·Status: COMPLETED
-
A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT03979807 ·Status: COMPLETED
-
Long-term Oxygen Treatment Trial
NCT00692198 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01204034 ·Status: COMPLETED ·Phase: PHASE3
-
Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease
NCT01019694 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162
NCT01348555 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Post-marketing Surveillance of Berodual® Metered-dose Inhaler in the Treatment of Chronic Obstructive Respiratory Tract Disease
NCT02231437 ·Status: COMPLETED
-
Peak Inspiratory Flow and Dry Powder Inhaler Performance in COPD
NCT04606394 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD
NCT02643082 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPD
NCT02371629 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Bronchodilators in Chronic Obstructive Pulmonary Disease and the Risk of Adverse Cardio-pulmonary Events
NCT02096731 ·Status: COMPLETED
-
Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and the Lung Availability of CHF 5993 in Healthy Volunteers
NCT02743013 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of Multiple Inhaled NVA237 Doses in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00545311 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02570165 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment Of The Inhalation Profiles Of Four Dry Powder Inhalers In Patients With Variable Degrees Of Lung Obstruction
NCT01033669 ·Status: COMPLETED
-
Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study.
NCT01260389 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
NCT01313676 ·Status: COMPLETED ·Phase: PHASE3
-
Combivent® HFA-propelled Compared to CFC-propelled Metered Dose Inhaler in Patients With COPD (Chronic Obstructive Pulmonary Disease)
NCT02182869 ·Status: TERMINATED ·Phase: PHASE2